Dr. Wolf is Founder and CEO of Wavegate Technologies, LLC. He is a practicing board-certified neurosurgeon with over 25 years experience in the neuromodulation field. Outside the operating room, Dr. Wolf's interests include medical device development, digital/analog electronics and instrumentation. Dr. Wolf attended Tulane University where he received his MD and PhD in Biomedical Engineering. An inventor and entrepreneur at heart, he has extensive experience with the biomedical product development cycle and acts in an advisory role for several biomedical device manufacturers . Dr. Wolf holds over 25 U.S. and International patents pertaining to medical devices.
D. Patrick O'Neal, PhD
Dr. Patrick O’Neal is an associate professor in Biomedical Engineering at Louisiana Tech University. He received a Ph. D. in Biomedical Engineering from Texas A&M University at College Station, and promotes clinical research and medical device development in the fields of opto-electronics, neuromodulation, and pharmacometrics. Throughout his career, he has published over 50 research articles in well-known scientific journals. His teaching over the past decade has focused on capstone courses and applied sciences, such as Medical Device Design, Applied Animal Physiology integrating digital signal processing, Biomedical Optics, and Nanomedicine. Prior to moving to academia, Patrick led several medical device development projects while serving as PI on numerous NSF (SBIR), NIH (STTR), and NIST (ATP) funded industry projects.
Robert A. Ehlers
CPA/ABV/CFF, CVA, CBA
Mr. Ehlers is the principal of Ehlers and Associates CPAs, LLC. Robert attended Louisiana State University and McNeese State University where he received a BS degree in accounting. Mr. Ehlers is a Certified Public Accountant, is Accredited in Business Valuation, Certified in Financial Forensics, a Certified Business Appraiser, a Certified Valuation Analyst, and is an ASA Candidate. Mr. Ehlers' experience includes performing and/or consulting in Federal securities actions, mergers and acquisitions, negotiated sales/due diligence, valuation defense, discount study, and stockholder buy-sell agreements. Mr. Ehlers has opined in valuation assignments totaling over $1 billion in equity and enterprise values.